Class GraphKB.Documents Extends %Persistent [ DdlAllowed ]
{

Property docid As %Library.String(MAXLEN = 200);

Property title As %Library.String(MAXLEN = 1000);

Property abstract As %Library.String(MAXLEN = 10000);

Property url As %Library.String(MAXLEN = 1000);

Property published As %Library.String(MAXLEN = 1000);

Property authors As %Library.String(MAXLEN = 1000);

ClassMethod LoadData(filepath As %Library.String, purge As %Library.Integer = 1) As %Status
{
    // purge - Whether to clean the table of previously loaded data; default to 1.
    if purge { // purge data
        set myquery = "TRUNCATE TABLE GraphKB.Documents"
        set tStatement = ##class(%SQL.Statement).%New()
        $$$ThrowOnError(tStatement.%Prepare(myquery))
        set rset = tStatement.%Execute()
    }

    set myquery = "LOAD DATA FROM FILE '"_filepath_"' INTO GraphKB.Documents USING {""from"":{""file"":{""header"":true}}}"
    set tStatement = ##class(%SQL.Statement).%New()
    $$$ThrowOnError(tStatement.%Prepare(myquery))
    set rset = tStatement.%Execute()
    if (rset.%SQLCODE < 0) {
        throw ##class(%Exception.SQL).CreateFromSQLCODE(rset.%SQLCODE, rset.%Message)
    }
    return rset
}

Storage Default
{
<Data name="DocumentsDefaultData">
<Value name="1">
<Value>%%CLASSNAME</Value>
</Value>
<Value name="2">
<Value>docid</Value>
</Value>
<Value name="3">
<Value>title</Value>
</Value>
<Value name="4">
<Value>abstract</Value>
</Value>
<Value name="5">
<Value>url</Value>
</Value>
<Value name="6">
<Value>authors</Value>
</Value>
<Value name="7">
<Value>published</Value>
</Value>
</Data>
<DataLocation>^GraphKB.DocumentsD</DataLocation>
<DefaultData>DocumentsDefaultData</DefaultData>
<ExtentSize>20</ExtentSize>
<IdLocation>^GraphKB.DocumentsD</IdLocation>
<IndexLocation>^GraphKB.DocumentsI</IndexLocation>
<Property name="%%CLASSNAME">
<AverageFieldSize>2</AverageFieldSize>
<Histogram>$lb(.06666666666666666667,0,16,$lb("-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000","-10000000000000000000"),$lb(21,21,21,21,21,21,21,21,21,21,21,21,21,21,21),$lb(758198320,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,758198320))</Histogram>
<OutlierSelectivity>.999999:</OutlierSelectivity>
<Selectivity>0.0001%</Selectivity>
</Property>
<Property name="%%ID">
<AverageFieldSize>3</AverageFieldSize>
<Histogram>$lb(.06666666666666666667,1,0,$lb(1,2,4,6,8,10,11,12,13,14,15,16,17,18,19,20),$lb(0,0,0,0,0,1,1,1,1,1,1,1,1,1,0),"")</Histogram>
<Selectivity>1</Selectivity>
</Property>
<Property name="abstract">
<AverageFieldSize>1334.6</AverageFieldSize>
<Histogram>$lb(.06666666666666666667,0,0,$lb(" AN EARLY PHASE CLINICAL TRIAL IS THE FIRST STEP IN EVALUATING THE EFFECTS INHUMANS OF A POTENTIAL NEW ANTI-DISEASE AGEN"," ANALYZING DATA FROM PAST CLINICAL TRIALS IS PART OF THE ONGOING EFFORT TOOPTIMIZE THE DESIGN, IMPLEMENTATION, AND EXECU"," CLINICAL TRIALS ARE ESSENTIAL TO DRUG DEVELOPMENT BUT TIME-CONSUMING, COSTLY,AND PRONE TO FAILURE. ACCURATE TRIAL OUTCO"," CLINICAL TRIALS ARE PIVOTAL IN MEDICAL RESEARCH, AND NLP CAN ENHANCE THEIRSUCCESS, WITH APPLICATION IN RECRUITMENT. THI"," IMMUNE CORRELATES OF PROTECTION (COPS) ARE IMMUNOLOGIC BIOMARKERS ACCEPTED ASA SURROGATE FOR AN INFECTIOUS DISEASE CLIN"," IN IMMUNOLOGICAL AND CLINICAL STUDIES, MATRIX-VALUED TIME-SERIES DATACLUSTERING IS INCREASINGLY POPULAR. RESEARCHERS AR"," NATURAL LANGUAGE PROCESSING (NLP) OF CLINICAL TRIAL DOCUMENTS CAN BE USEFULIN NEW TRIAL DESIGN. HERE WE IDENTIFY ENTITY"," NEW MEDICAL TREATMENT DEVELOPMENT REQUIRES MULTIPLE PHASES OF CLINICALTRIALS. DESPITE THE SIGNIFICANT HUMAN AND FINANCI"," PHASE 1-2 DESIGNS PROVIDE A METHODOLOGICAL ADVANCE OVER PHASE 1 DESIGNS FORDOSE FINDING BY USING BOTH CLINICAL RESPONSE"," PILOT STUDIES OF STRUCTURED TREATMENT INTERRUPTIONS (STI) IN HIV THERAPY HAVESHOWN THAT PATIENTS CAN MAINTAIN LOW VIRAL"," THE ABILITY TO ASSESS SLEEP AT HOME, CAPTURE SLEEP STAGES, AND DETECT THEOCCURRENCE OF APNEA (WITHOUT ON-BODY SENSORS) "," THE ADVENT AND SUBSEQUENT WIDESPREAD AVAILABILITY OF PREVENTIVE VACCINES HASALTERED THE COURSE OF PUBLIC HEALTH OVER TH"," THE GLOBAL COST OF DRUG DISCOVERY AND DEVELOPMENT EXCEEDS $200 BILLIONANNUALLY. THE MAIN RESULTS OF DRUG DISCOVERY AND "," THE INTERPRETATION OF VACCINE EFFICACY ESTIMANDS IS SUBTLE, EVEN INRANDOMIZED TRIALS DESIGNED TO QUANTIFY IMMUNOLOGICAL"," THE REUSE OF HISTORICAL CLINICAL TRIAL DATA HAS SIGNIFICANT POTENTIAL TOACCELERATE MEDICAL RESEARCH AND DRUG DEVELOPMEN"," THE WORLD HEALTH ORGANIZATION (WHO) GUIDELINES FOR MONITORING THEEFFECTIVENESS OF HIV TREATMENT IN RESOURCE-LIMITED SET"),$lb(3,1,21,1,2,1,2,1,2,1,6,5,5,5,5),$lb(541150752,541409618,1095522650,1095647564,1129072974,1163088709,1346983503,1129072974,1229802837,1296913742,1310738765,1229856841,1312904277,1096045906,1163337805,1313167136,1346912595,1212240709,1229737812,1346980943,1414022432,1112099913,1146504526,1094997573,1196183362,1196183362,1229870149,1229870149,1380275539,1380275539,1464816204,542394437))</Histogram>
<Selectivity>5.0000%</Selectivity>
</Property>
<Property name="authors">
<AverageFieldSize>56.4</AverageFieldSize>
<Histogram>$lb(.06666666666666666667,0,0,$lb(" CHENG-HAN YANG,PETER F. THALL,RUITAO LIN"," CHUFAN GAO,JATHURSHAN PRADEEPKUMAR,TRISHA DAS,SHIVASHANKAR THATI,JIMENG SUN"," HAO HE,CHAO LI,WOLFGANG GANGLBERGER,KAILEIGH GALLAGHER,RUMEN HRISTOV,MICHAIL OUROUTZOGLOU,HAOQI SUN,JIMENG SUN,BRANDON "," LEYING GUAN"," MICHAEL REINISCH,JIANFENG HE,CHENXI LIAO,SAULEH AHMAD SIDDIQUI,BEI XIAO"," NIMA S. HEJAZI,MARK J. VAN DER LAAN,HOLLY E. JANES,PETER B. GILBERT,DAVID C. BENKESER"," PETER B. GILBERT,YOUYI FONG,MARCO CARONE"," PETER F. THALL"," ROMULUS BREBAN,SALLY BLOWER"," ROSS M. KEDL"," TAO LIU,JOSEPH W. HOGAN,LISA WANG,SHANGXUAN ZHANG,RAMI KANTOR"," TIANYU ZHAN,YIWANG ZHOU,ZIQIAN GENG,YIHUA GU,JIAN KANG,LI WANG,XIAOHONG HUANG,ELIZABETH H. SLATE"," XIONG LIU,GREG L. HERSCH,IYA KHALIL,MURTHY DEVARAKONDA"," YUMENG YANG,ASHLEY GILLIAM,ETHAN B LUDMIR,KIRK ROBERTS"," ZIFENG WANG,CAO XIAO,JIMENG SUN"," ZIFENG WANG,JIMENG SUN"),$lb(3,1,1,1,1,1,7,1,3,1,2,1,1,1,13),$lb(541280325,1162757933,1430667598,1128813894,1212239648,1212239648,1279613257,1279613257,1296646984,1296646984,1313426753,1313426753,1346720837,1110319175,1177428052,1346720837,1380928853,1297435733,1397956685,1380930387,1413566240,1095704652,1229016665,1414086990,1481199438,1481199438,1498762565,1498762565,1514751557,1128353568,1246317893,542787910))</Histogram>
<Selectivity>5.0000%</Selectivity>
</Property>
<Property name="docid">
<AverageFieldSize>3.5</AverageFieldSize>
<Histogram>$lb(.06666666666666666667,0,0,$lb(" 0"," 1"," 11"," 13"," 15"," 17"," 18"," 19"," 2"," 3"," 4"," 5"," 6"," 7"," 8"," 9"),$lb(1,2,2,2,2,2,2,1,1,1,1,1,1,1,1),$lb(540016640,805306368,822083584,0,822083584,822083584,855638016,855638016,889192448,889192448,922746880,922746880,939524096,939524096,956301312,825819136,838860800,838860800,855638016,855638016,872415232,872415232,889192448,889192448,905969664,905969664,922746880,922746880,939524096,939524096,956301312,540606464))</Histogram>
<Selectivity>5.0000%</Selectivity>
</Property>
<Property name="title">
<AverageFieldSize>91.25</AverageFieldSize>
<Histogram>$lb(.06666666666666666667,0,0,$lb(" AN IMMUNOLOGICAL AUTOBIOGRAPHY: MY YEAR AS A COVID-19 VACCINE TRIAL PARTICIPANT"," ASSESSMENT OF IMMUNE CORRELATES OF PROTECTION VIA CONTROLLED VACCINE EFFICACY AND CONTROLLED RISK"," BAYESIAN MODELS AND DECISION ALGORITHMS FOR COMPLEX EARLY PHASE CLINICAL TRIALS"," CTP-LLM: CLINICAL TRIAL PHASE TRANSITION PREDICTION USING LARGE LANGUAGE MODELS"," DEMO: DOSE EXPLORATION, MONITORING, AND OPTIMIZATION USING A BIOLOGICAL MEDIATOR FOR CLINICAL OUTCOMES"," EFFICIENT NONPARAMETRIC INFERENCE ON THE EFFECTS OF STOCHASTIC INTERVENTIONS UNDER TWO-PHASE SAMPLING, WITH APPLICATION"," EXPLORING THE GENERALIZATION OF CANCER CLINICAL TRIAL ELIGIBILITY CLASSIFIERS ACROSS DISEASES"," OPTIMAL ALLOCATION OF GOLD STANDARD TESTING UNDER CONSTRAINED AVAILABILITY: APPLICATION TO ASSESSMENT OF HIV TREATMENT "," PANACEA: A FOUNDATION MODEL FOR CLINICAL TRIAL SEARCH, SUMMARIZATION, DESIGN, AND RECRUITMENT"," PARAMETRIC RESONANCE MAY EXPLAIN VIROLOGIC FAILURE TO HIV TREATMENT INTERRUPTIONS"," SMOOTH AND PROBABILISTIC PARAFAC MODEL WITH AUXILIARY COVARIATES"," SPOT: SEQUENTIAL PREDICTIVE MODELING OF CLINICAL TRIAL OUTCOME WITH META-LEARNING"," TRIAL2VEC: ZERO-SHOT CLINICAL TRIAL DOCUMENT SIMILARITY SEARCH USING SELF-SUPERVISION"," TRIALSYNTH: GENERATION OF SYNTHETIC SEQUENTIAL CLINICAL TRIAL DATA"," UNLOCKING HISTORICAL CLINICAL TRIAL DATA WITH ALIGN: A COMPOSITIONAL LARGE LANGUAGE MODEL SYSTEM FOR MEDICAL CODING"," WHAT RADIO WAVES TELL US ABOUT SLEEP"),$lb(2,1,1,1,1,2,1,1,3,1,2,1,6,1,1),$lb(541150752,1310738765,1397966163,1095979845,1111578949,1111578949,1129599021,1129599021,1145392463,1145392463,1162233417,1179011395,1481657423,1163415628,1330664521,1330664521,1346457153,1312899909,1380011333,1346458177,1397575503,1297043284,1347376186,1397772116,1414678849,844514627,1398361684,1414678849,1431194703,1431194703,1464353108,542591041))</Histogram>
<Selectivity>5.0000%</Selectivity>
</Property>
<Property name="url">
<AverageFieldSize>35.1</AverageFieldSize>
<Histogram>$lb(.06666666666666666667,0,0,$lb(" HTTP://ARXIV.ORG/ABS/1011.6494V1"," HTTP://ARXIV.ORG/ABS/2003.13771V2"," HTTP://ARXIV.ORG/ABS/2010.00692V1"," HTTP://ARXIV.ORG/ABS/2107.05734V1"," HTTP://ARXIV.ORG/ABS/2111.01282V2"," HTTP://ARXIV.ORG/ABS/2304.05352V1"," HTTP://ARXIV.ORG/ABS/2311.08335V1"," HTTP://ARXIV.ORG/ABS/2403.17135V1"," HTTP://ARXIV.ORG/ABS/2404.02120V1"," HTTP://ARXIV.ORG/ABS/2405.11739V2"," HTTP://ARXIV.ORG/ABS/2406.10292V1"," HTTP://ARXIV.ORG/ABS/2407.11007V1"," HTTP://ARXIV.ORG/ABS/2408.10995V1"," HTTP://ARXIV.ORG/ABS/2409.07089V2"," HTTP://ARXIV.ORG/ABS/2411.13163V1"," HTTP://ARXIV.ORG/ABS/Q-BIO/0504031V1"),$lb(22,24,23,24,23,24,23,25,25,25,25,25,25,24,22),$lb(541611092,825241905,842018867,808660529,825241136,808529966,825243438,808922672,825306672,825307438,858797102,808726064,825306672,858861870,875574062,858665271,875442226,875442226,892219697,892219697,908996912,908996912,925774129,925774129,942551344,942551344,959328311,809053744,825306673,842281265,1361920585,541611092))</Histogram>
<Selectivity>5.0000%</Selectivity>
</Property>
<SQLMap name="IDKEY">
<BlockCount>-20</BlockCount>
</SQLMap>
<StreamLocation>^GraphKB.DocumentsS</StreamLocation>
<Type>%Storage.Persistent</Type>
}

}
